心血管疗法中的新型炎症生物标记物

Title:Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Volume: 22 Issue: 23

Author(s): Vicky Tsigkou, Gerasimos Siasos, Evangelos Oikonomou, Marina Zaromitidou, George Latsios, Manolis Vavuranakis, Spyridon Deftereos, Michael W. Cleman, Eleni Kokkou, Maria Limberi, Stathis Dimitropoulos,, Thodoris Zografos, Smaragdi Marinaki, Christodoulos Stefanadis and Dimitris Tousoulis

Affiliation:

关键词: 动脉粥样硬化，生物标记物，心血管疾病，冠心病，心力衰竭，高血压，炎症，外周动脉疾病，中风。

摘要: Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.

Cite this article as:

Vicky Tsigkou , Gerasimos Siasos , Evangelos Oikonomou , Marina Zaromitidou , George Latsios , Manolis Vavuranakis , Spyridon Deftereos , Michael W. Cleman , Eleni Kokkou , Maria Limberi , Stathis Dimitropoulos, , Thodoris Zografos , Smaragdi Marinaki , Christodoulos Stefanadis and Dimitris Tousoulis , Novel Inflammatory Biomarkers in Cardiovascular Therapeutics, Current Medicinal Chemistry 2015; 22 (23) . https://dx.doi.org/10.2174/0929867322666150429110124